FCGRT and viral infectious disease: Since viral infections in utero and during the neonatal period have been associated with increased risk of developing T1D in childhood (85, 87–90), the antiviral protection afforded to offspring via FcRn delivery of maternal antibodies suggests a possible link between the function of FcRn and T1D risk in genetically susceptible individuals.